Inventor · disambiguated record
Anne-Laure Flamar
Also filed as: FLAMAR ANNE-LAURE
17 granted patents·7 pending applications·399 citations·filing 2008–2021
95Inventor score
Files withZURAWSKI GERARD8BAYLOR RES INST7BAYLOR RES INSTITUTE4INST NAT SANTE RECH MED3BANCHEREAU JACQUES F1
Top patents by PatentIndex Score
24 records- 0197US9234040B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Jan 12, 2016·26 cites·13 claims
- 0297US9102730B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Aug 11, 2015·25 cites·8 claims
- 0397US8518410B2Fusion protein with HIV antigenZURAWSKI GERARD·Filed 2010·Granted Aug 27, 2013·50 cites·22 claims
- 0497US8449888B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2011·Granted May 28, 2013·35 cites·8 claims
- 0596US8961991B2Anti-CD40 targeted fusion proteinsZURAWSKI GERARD·Filed 2010·Granted Feb 24, 2015·48 cites·18 claims
- 0696US7786267B2Multivariable antigens complexed with targeting humanized monoclonal antibodyBAYLOR RES INST·Filed 2008·Granted Aug 31, 2010·48 cites·10 claims
- 0795US9416186B2Antigen presenting cell targeted anti-viral vaccinesZURAWSKI GERARD·Filed 2013·Granted Aug 16, 2016·27 cites·9 claims
- 0895US9102734B2Fusion proteins comprising antibody and HPV E6 and E7 antigensZURAWSKI GERARD·Filed 2010·Granted Aug 11, 2015·46 cites·13 claims
- 0995US8586052B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2012·Granted Nov 19, 2013·27 cites·10 claims
- 1093US11806390B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2021·Granted Nov 7, 2023·2 cites·14 claims
- 1192US11219683B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2020·Granted Jan 11, 2022·2 cites·14 claims
- 1291US10610585B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2018·Granted Apr 7, 2020·3 cites·25 claims
- 1390US9109011B2Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/NefBANCHEREAU JACQUES F·Filed 2009·Granted Aug 18, 2015·27 cites·5 claims
- 1490US8057798B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERALD·Filed 2008·Granted Nov 15, 2011·30 cites·5 claims
- 1585US10988544B2Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptidesBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 27, 2021·1 cites·11 claims
- 1683US10722572B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2019·Granted Jul 28, 2020·1 cites·29 claims
- 1780US10980869B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 20, 2021·1 cites·7 claims
- 1875US2021221904A1Fusion proteins comprising an anti-cd40 antibody and hiv antigenic peptidesBAYLOR RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1955US2015299329A1Antigen presenting cell targeted vaccinesBAYLOR RES INST·Filed 2015·Application pending·0 cites
- 2054US2016031988A1Multivariable antigens complexed with targeting humanized monoclonal antibodyBAYLOR RES INST·Filed 2015·Application pending·0 cites
- 2152US2010330115A1Multivariable Antigens Complexed with Targeting Humanized Monoclonal AntibodyBAYLOR RES INST·Filed 2010·Application pending·0 cites
- 2251US2016022792A1Antigen presenting cell targeted cancer vaccinesBAYLOR RES INST·Filed 2015·Application pending·0 cites
- 2342US2012231023A1Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting CellsZURAWSKI GERARD·Filed 2012·Application pending·0 cites
- 2440US2012039916A1Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cellsZURAWSKI GERARD·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →